๐
MO Q1 2022 Earnings Call
April 28, 2022 at 12:00 AM
๐
Company
MO
Quarter
Q1 2022
Date
April 28, 2022 at 12:00 AM
Speakers
2
Word Count
~5,671
Transcript Content
Operator
We will take questions from the investment community first. Our first question comes from Chris Growe from Stifel.
Speaker
I have a question for you. There seems to be a macro headwind affecting things. Some areas, like wages, appear to be performing better. Considering factors like unemployment and gas prices, when do you anticipate this will have less of a negative impact on volume this year? Additionally, regarding the Marlboro franchise, Marlboro's market share was quite strong this quarter. Are consumers shifting their preferences within the Marlboro brand, for example, towards different blends? Billy Gifford (CEO): Yes. Thanks for the question, Chris. I'll take them in order. So from a standpoint, we were excited to see the resilience of our consumer. And that's why we wanted to highlight the wage inflation that I think a number of industries don't see and it's benefited our tobacco consumer. It's something that we'll continue to watch. Certainly, gas prices have an impact on our consumers because usually they're filling up their car truck and then going in and purchasing the product. So it's something that we'll continue to watch, but we feel pleased through the first quarter with the resiliency we've seen in the tobacco consumer. As far as Marlboro, we're extremely excited with the stability of Marlboro. And if you go back, you can see pre-COVID, we had the benefit of the strength of Marlboro. And we benefited from the consumer having extra discretionary income as we proceeded through the COVID pandemic. And I think that pointed to that Marlboro's still the aspirational brand in the marketplace. And then as we've seen discretionary income come under pressure, we gave a little bit of that share back that we had benefited during the COVID virus. But through that entire period, the Marlboro brand has held up. You always see a little bit of movement. If you think about Marlboro as the brand, it has over 90% loyalty. That's a consumer that's buying it every time they make a purchase of a cigarette in the marketplace. But you see a little bit of movement, but nothing that I would highlight for you at this point.
Speaker
Okay. I just had one other question. I think you talked about the dynamic of consumers moving into vape shops, for example, for vapor. And is that a movement away from traditional outlets? And I guess just what could be driving that? And I guess, to that effect, what that could mean to JUUL in the future based on that movement by consumers? Billy Gifford (CEO): Yes. What we tried to highlight was where we saw some of the growth. It was in the vape shop channel. Again, no trend there to highlight. Just wanted to highlight where we saw the growth sequentially. I think if you step back and look at the entire e-vapor category, what we've tried to highlight is as all of these products are coming under FDA regulation, and we should see and have started seeing some of the decisions by the FDA, I think that entire category will be in a bit of a transition over the next year to 18 months as some products make it through the process and some are denied. And so those consumers will be moving around a bit. What we look forward to and continue to believe is that e-vapor can play an important role in harm reduction in the U.S. once we get to a total FDA-authorized marketplace.
Operator
Our next question comes from Vivien Azer from Cowen.
Speaker
So the menthol news has been long anticipated, certainly over the last 12 months given the April 2022 target. Billy, maybe it will be helpful. You guys have been pretty consistent in disclosing your share of menthol, but just dimensionalizing how big the menthol category is in the broader category context. Billy Gifford (CEO): Yes. So to your point on our metrics page, you can see our share of menthol is 9.4% across PM USA, and it's pretty consistent from an industry standpoint that it represents about one-third of industry from a menthol cigarettes in the marketplace versus non-menthol.
Speaker
Understood. That's really helpful. My next question is on the IRS call out. That's a bit of a unique call out relative to what we've been hearing from other companies under my coverage. So is the message that this is kind of a one-quarter benefit? Like how are you guys kind of thinking about that? Like does it annualized? Or are you kind of thought that, that was kind of a one-time offset to inflationary pressures for the consumer? Billy Gifford (CEO): Yes, you can view it as a form of government stimulus to some degree, Vivien. The actual refund checks are on the rise. We'll see how that develops through the second quarter since not everyone receives their refund checks in the first quarter. However, we certainly want to emphasize it for our consumers. The more significant point, which you noticed, was the wage inflation. That aspect is benefiting our consumers, and we expect it to remain consistent throughout the year.
Operator
Our next question comes from Pamela Kaufman from Morgan Stanley.
Speaker
Can you give an update on your strategy in the oral tobacco segment? Performance reflects continued elevated investment behind on! How should we think about profitability in this segment and how it evolves? And is there a level of market share or particular goalpost that you can point to that would drive a shift towards more of a profit focus for on!? Billy Gifford (CEO): I appreciate the question, Pamela. Our strategy in oral tobacco focuses on maximizing long-term profitability in the moist smokeless category, leveraging the strength of Copenhagen, while responsibly investing in on! to sustain its growth. We believe that over time, we can achieve margins similar to traditional tobacco products in the oral nicotine pouch category. However, we are currently in an investment phase. You noted the significant year-over-year growth, almost doubling our volume from the first quarter last year. We have aimed to emphasize that after overcoming manufacturing capacity constraints, we wanted to invest to ensure our product is considered by consumers choosing alternative options. We're now utilizing our advanced analytics to target our promotions more effectively. Yet, we remain in this investment period for some time.
Speaker
Great. And then can you discuss what you're observing from the competitive landscape within the cigarette category in light of the current consumer environment? The deep discount segment continues to gain share at a higher pace, and price gaps remain wide relative to historical levels. Can you talk about how you're thinking about trade down within the cigarette category given some of the consumer headwinds? Billy Gifford (CEO): Yes, sure. Some of what you've seen is exactly what you highlighted, Pamela, which is as the discretionary income comes under pressure, whether that's through inflation or gas prices or even mobility, you'll see some trade down. I think if you think about the total cigarette consumer group, think about it as a bit of a barbell. There's a group of consumers that are at the bottom end of that, that are always buying the cheapest in the store. And so you see that occur. You saw the benefit in Marlboro that we experienced when discretionary income wasn't under so much pressure. But the way we think about it is we're a premium-focused company, and you see this, the rock-solid stability of Marlboro through time.
Operator
The next question comes from Gaurav Jain from Barclays.
Speaker
So a couple of questions here. Billy, so the Slide #6 in which you are talking about how wages are trending across different professions is very interesting. Now if I apply a similar sort of lens to the entire U.S. and different states and maybe different wage inflation in different states, are you seeing better volume trends in the states where wage inflation is higher versus where wage inflation is lower? Billy Gifford (CEO): Yes, it's an interesting question. We don't disclose to that level, but we do see where wage inflation has benefited consumer spending, and that's why we wanted to highlight that for you.
Speaker
Sure. I believe that wage inflation is likely to increase as we move through this year, considering the weekly jobless data and the fact that the Federal Reserve is still behind the curve. Should we then anticipate that cigarette volumes, which dropped 6.5% in Q1 due to challenging comparisons and the spike in gas prices, will begin to stabilize and improve as the year continues? Billy Gifford (CEO): Yes. I think the macroeconomic environment, to your point, is very dynamic. Certainly, we would expect wage inflation to at least be consistent throughout the year. In your hypothesis of it increasing, I guess, we'll see on how unemployment goes and how job openings respond to that. I think the other side, though, is the tailwind. You highlighted gas prices. We'll see where gas prices go through the remainder part of the year and where inflation trends. So I think it's very dynamic, and that's why we wanted to highlight some of the tailwinds and headwinds that we were seeing.
Speaker
Sure. And coming to the synthetic nicotine market and what the FDA has done. So in the synthetic nicotine market, like how do you see this entire category playing out in the next few months and will that be a benefit to your volumes as well? Billy Gifford (CEO): Yes. So when you think about the total nicotine, you've seen us highlight that a couple of times and really looking at how the consumer is moving around. And that's exactly why, Gaurav, we put the portfolio approach in place because FDA decisions in one category put consumers at play and force them to other categories. And so we believe in having the portfolio approach is important. And so you can take the e-vapor category, depending on the decisions made by the FDA, that's why we highlight that, that category could be in a bit of a transition for the next year to 18 months as decisions come out and some products make it through and some products do not. Those consumers for products that do not make it will be at play either for other e-vapor products or other categories that they have in their consideration set.
Speaker
Sure. And if I could just sneak in a last one for Sal. So Sal, there's this net periodic benefit income line item in your P&L, which has been a constant benefit. And I used to think that when interest rates go up, it will become a headwind, but it hasn't. So how does this line item work? Sal Mancuso (CFO): Can you repeat that? I apologize.
Speaker
The net periodic benefit income, that line item, which I think is linked to your pension, interest and income and expense. So it has always been a tailwind to your P&L. And I thought that it would become a headwind as interest rates rise, but still there is a benefit that's happening. So how do... Sal Mancuso (CFO): That's a reflection of the strength of our pension plan funding and also some favorability in our overall pension plan performance, which gets amortized over time. So you are correct that it has provided a slight benefit to our P&L.
Operator
Our next question comes from Bonnie Herzog from Goldman Sachs.
Speaker
I wanted to follow up on your cigarette volumes, considering some investor concerns about your volume in this environment, particularly your premium Marlboro volume due to the wider price gap. First, Billy, could you let us know if your Q1 results met your expectations? Additionally, can you provide more details about your strategy to protect your volume and market share? I believe you are increasing promotional spending for some price-sensitive consumers. Could you also explain how you utilize your special select brands during these times to keep more consumers within your Marlboro franchise? Lastly, I would like to understand why there isn't a better balance between your pricing and volumes. Billy Gifford (CEO): Yes, Bonnie. Iโll do my best to address your points. There are several aspects to cover, but Iโll focus on the strategy weโve put in place. As youโve seen with Marlboro, its performance has been consistently strong over time. Regarding pricing and promotions in the market, weโve emphasized our use of advanced analytics and revenue growth management to better connect with consumers. This means if we are running promotions, we can tailor them more closely to individual consumers. We have various retail trade programs designed to offer multiple solutions, whether at the store level or across larger geographic areas, taking into account that consumer economic conditions differ by state. Additionally, I want to highlight that our price realization involves two components: the list price and the efficiencies gained through our revenue growth management and analytics. When you consider these factors together, you can see the stability of Marlboro and the efficiency of our promotional strategies, which enables us to allocate our promotional spending more effectively. Sal Mancuso (CFO): Bonnie, I would just add one other point, which we highlighted in our opening remarks. I think the strength of Marlboro's performance within the premium category, where share of premium has grown as a reflection of the effectiveness of the programs and tools Billy just mentioned.
Speaker
All right. Yes. I mean, so I guess the right way to think about your smokeable business, I mean it's an industry that's in secular decline in terms of volumes. They've been declining for a very, very long time. So the way you're managing this is offsetting that with pricing and trying to drive, whether it's low or mid-single-digit operating income growth and expanding your margins. And you feel good, even in this environment, that you're going to be able to continue to do that. Billy Gifford (CEO): Yes, as indicated by our results for the first quarter, it was a challenging macroeconomic environment. Many industries were affected, but we managed to navigate through it effectively. I want to emphasize that with our advanced analytics and available tools, we are able to be much more precise. When reviewing the 12-month decomposition of volume, it shows that total price elasticity remains stable. Itโs clear that the changes we see are primarily due to macroeconomic factors.
Speaker
And just one quick final clarification just on your guidance. Can you touch on what it assumes in terms of total industry cigarette volumes? I mean are you assuming that volumes decelerate further this year? Any color on that would be helpful to kind of frame all of this. Billy Gifford (CEO): I appreciate your question, Bonnie. I understand you're seeking volume guidance, but we don't provide that. In this dynamic marketplace, we offer a range of guidance because we anticipate changes in our consumer base. Our aim is to meet consumer needs, which is why we present a range. Volume is just one aspect of our guidance, which includes multiple factors. Therefore, focusing on a single factor may not be appropriate. We are confident in reaffirming our guidance for the quarter, and it's important to monitor how consumers are navigating the current macroeconomic conditions.
Operator
Our next question comes from Priya Ohri-Gupta from Barclays.
Speaker
Sal, I was wondering if you could just provide us with some thoughts on your outlook for the refinancing market. You do have a little over $1 billion maturing later this year and how you're thinking about other opportunities for perhaps greater interest expense management across your debt portfolio? And then secondly, you do have one of your euro bonds maturing early in 2023. If I recall, that serves as a net investment hedge against the dividend you received from ABI. So strategically, how should we think about sort of the need to refinance that in euro versus sort of refinancing in dollar? Sal Mancuso (CFO): Sure. I'll address those questions one at a time. First, it's essential for us to continue maintaining a strong balance sheet moving forward. Last year, as part of our capital allocation strategy, we refinanced some of our debt, which helped extend the maturities of lower interest debt. We are satisfied with the results of that transaction. We also manage our debt structure carefully to minimize the impact of market fluctuations and to maintain flexibility regarding maturing debt. While I can't predict exactly how we will address the upcoming maturing debt, we will conduct a thorough analysis to determine the optimal course of action, whether that involves using existing cash to pay it off or considering refinancing options. The same approach applies to the euro debt that is coming due. We recognize that it serves as a natural hedge against the dividends from ABI. We have the flexibility to explore opportunities in various markets, whether it involves managing our balance sheet, refinancing, or handling debt as it matures.
Operator
And we have a question from Gaurav Jain from Barclays again.
Speaker
Just a quick question on the ABI stake. Believe, Sal, like any updated thoughts on how you are thinking about it. Sal Mancuso (CFO): There's really nothing new to say. We continue to perform the analysis related to our ABI stake. As we spoke about in our opening remarks, it's a financial investment. Our focus is on maximizing that investment for the long-term shareholder value. We continue to do the analysis, and there's nothing new to report on the asset itself.
Operator
We will now take questions from the media representatives. And our next question comes from Jennifer Maloney from Wall Street Journal. Jennifer Maloney (Analyst โ Journalist): I wanted to ask about consumer switching patterns that you would expect to see if a menthol ban were implemented either in the state of California or nationwide. First of all, would you expect to see Newport smokers switching to Marlboro? And if so, what net impact would you expect to see on your overall cigarette business? Billy Gifford (CEO): Yes. I think it's tough to say. I think with some of the alternative products that are in the marketplace, certainly, if there were an outright ban using your hypothetical of menthol, the consumer for the menthol cigarettes will either go to the illegal market, as we highlighted under unintended consequences of an outright ban, or look to either non-menthol cigarettes or alternative products. So it's tough to say where that will go. I think if you look at some of the research, there's limited research on it, but some would say that they would convert to non-menthol cigarettes. I think the better point here, though, is if you step back, prohibition, at least through history, hasn't worked. The better approach is to have these alternative products and allow we know consumers want to move to alternative products that have the potential to reduce harm. That seems like that should be the focus and a better approach than an outright ban. Jennifer Maloney (Analyst โ Journalist): One quick follow-up. What products would you expect Marlboro menthol smokers to switch to? And would you market any products specifically to them in the event of a menthol cigarette brand like Marlboro Gold or JUUL or on! Billy Gifford (CEO): Yes. We'll have to wait to see what the proposal that comes out and how it approaches menthol. We would really look to, as we said, to support our vision and really look to move the consumer down the continuum of risk. And so that's the way we would approach it with the alternative products that are in the marketplace. But certainly, it's ultimately the consumer's choice. Mac Livingston (Head of Investor Relations): Thank you all for joining us this morning. Please feel free to contact the Investor Relations team if you have further questions. Thanks again.
Operator
This does conclude today's program. Thank you for your participation. You may disconnect at this time. Have a great day.
Need more earnings data?
Explore more earnings information and financial data for MO
Transcript sourced from Financial Modeling Prep (FMP)